Key Takeaways from ADA's Scientific Sessions:

Key Takeaways from ADA's Scientific Sessions:

The American Diabetes Association's (ADA) Scientific Sessions in Chicago this June is set to showcase the latest developments in continuous glucose monitors (CGMs) for people with Type 2 diabetes. This year's event is focusing on new advancements in diabetes treatments, and the CGMs are at the forefront.

Abbott is leading the charge with its next-generation continuous glucose-ketone monitoring system (CKM), expected to launch in 2026. This groundbreaking system will continuously monitor both glucose and ketone levels, helping to prevent diabetic ketoacidosis (DKA), a serious complication. Abbott’s new CKM will integrate with multiple devices from Tandem, Medtronic, Sequel, and Beta Bionics, expanding its interoperability and appeal for intensive diabetes management beyond Type 1 diabetes.

Abbott's Libre CGM business has also seen strong growth, with $1.9 billion sales in Q2 2025, up 21.4% Year-over-Year (YoY), partly driven by increased reimbursement for CGM use in basal insulin-using populations, which typically includes many Type 2 diabetes patients. Abbott is also working on a new sensor expected to further accelerate market growth.

Dexcom continues to refine its CGM technology, having launched the G7 system in North America and Europe, which features a faster warm-up time and smaller size, facilitating more user-friendly continuous monitoring. Dexcom’s sensors have cleared FDA regulatory pathways, demonstrating strong clinical and analytical validity. Dexcom also recently issued a recall update for one of its CGM receivers due to serious adverse events, highlighting ongoing safety vigilance.

These technological advancements align with the 2025 ADA standards of care, which expand CGM recommendations to include individuals with Type 2 diabetes, particularly those on insulin therapy or at risk of hypoglycemia. The standards highlight the benefits of real-time glucose monitoring for better glycemic control and reduced hypoglycemia episodes, supporting the integration of these advanced CGMs into clinical practice.

Moreover, emerging technologies like implantable CGMs (e.g., Senseonics' Eversense 365 with up to one year wear) and novel biochemical sensing methods (e.g., Glucotrack's implanted venous sensor) are expected to enter the market in coming years, potentially offering even longer-term glucose monitoring options for patients with Type 2 diabetes.

In summary:

| Company | Latest Development | Expected Launch | Alignment with ADA 2025 Standards | |---------|--------------------|-----------------|----------------------------------| | Abbott | Continuous glucose-ketone monitor (CKM), new dual sensor under development | 2026 (CKM), ongoing for new sensors | Supports ADA’s expanded CGM recommendations, enabling DKA prevention and better glycemic control | | Dexcom | G7 system with faster warm-up, smaller size; regulatory clearance for G6 and G7 | Recently launched | Supports wider CGM adoption in Type 2 diabetes, consistent with ADA guidance | | Others (e.g., Senseonics, Glucotrack) | Implantable CGM devices with longer wear periods | 2025-2028 expected | Align with trends toward less invasive, longer-term monitoring |

The ADA 2025 guidelines advocate CGM use in broader Type 2 populations, and the current Abbott and Dexcom innovations directly contribute to making CGM more accessible, accurate, and integrated in routine diabetes care.

While much progress is made, issues such as device limitations (e.g., interference factors), cost, and user education remain important considerations in CGM adoption for people with Type 2 diabetes.

References:

1. Elise Reuter, "Why Medtronic plans to spin out its diabetes business".
2. Medtronic 2025 Fiscal Year Results
3. Needham analyst Mike Matson believes the separation of Medtronic's diabetes business will take time to create value.
4. Medtronic plans to spin out its diabetes business into a separate, publicly traded company named MiniMed.
5. Abbott's Libre CGM sales surge 21.4% in Q2 2025
6. Dexcom received FDA clearance for a 15-day version of its G7 CGM in April.
7. Ricky Zipp wrote an article titled "Beta Bionics CEO, CFO on how to take a company public".
8. FDA granted expanded labels to Insulet and Tandem Diabetes Care for their automated insulin delivery systems to be used by people with Type 2 diabetes last year.
9. Beta Bionics will host a demonstration of its patch pump at a Sunday investor event.
10. Beta Bionics went public in January.
11. Access to CGMs and insulin pumps has expanded in the past year due to FDA device label expansions, insurer coverage extensions, and ADA guideline updates.
12. Dexcom will present data at ADA this year on the benefits of CGM use for people with Type 2 diabetes across various insulin therapies.
13. Tandem Diabetes Care is developing a tubeless feature for its Mobi insulin pumps and a separate patch pump after acquiring AMF Medical.
14. Medtronic is working on an expanded label for its 780G pump to be used with its Simplera Sync sensor by people with Type 2 diabetes.
15. New ADA standards of care have been established, expanding access to continuous glucose monitors for adults with Type 2 diabetes who are on glucose-lowering medications other than insulin.
16. The conference is focusing on new developments in diabetes treatments.
17. Abbott is developing a dual-analyte sensor that can detect both blood glucose and ketones.
18. The Medtronic diabetes business, based in Northridge, California, has over 8,000 employees.
19. The expanding Medtech industry is marked by advancements in devices like continuous glucose monitors (CGMs) for people with Type 2 diabetes, as seen in the ADA's focus on these trends.
20. Research on AI and science in the health and wellness sector is driving progress in preventing medical-conditions such as diabetic ketoacidosis (DKA) through devices like Abbott's next-generation CKM.
21. Earnings from medtech giants, such as Abbott's Libre CGM business with $1.9 billion in Q2 2025, reflect the growing demand for technology in managing health issues.
22. Recalls, like the recent one issued by Dexcom for one of its CGM receivers, underscore the importance of ensuring safety and quality in technology development.
23. The finance sector plays a crucial role in the incorporation of technology into healthcare, with investments shaping the future of devices like CGMs and smart-home devices for health-and-wellness purposes.
24. Manufacturing is at the heart of producing medtech devices, playing a decisive role in quality, efficiency, and timely delivery of CGMs and other innovative medical technology.
25. The industry news landscape is rich with stories on the latest developments in CGMs and other devices, keeping the public informed on industry advancements and their impact on lifestyle and outdoor living.
26. Real-estate developments may increasingly include features that encourage sustainable living, such as eco-friendly appliances, home sensors, and energy-efficient solutions, thus integrating technology into the housing market.
27. The global cuisines industry is evolving with knowledge from technology and science to deliver healthy cooking options for consumers, promoting overall health-and-wellness.
28. The investment sector is essential for the growth of businesses that produce technology for household appliances, garden tools, and other smart-home devices, enhancing daily living experiences.
29. The housing market thrives on being informed about the latest trends, such as smart home technology and sustainable living options, for both budget-conscious and high-end consumers.
30. Budget travelers can save money while experiencing cultural travel through research and the use of GPS devices, travel apps, booking platforms, and other gadgets.
31. Adventure travelers rely on technology for planning, navigation, communication, and safety, making sustainable exploration possible while preserving the environment's beauty.
32. Culinary enthusiasts can explore global cuisines efficiently through online platforms, recipe apps, and connected kitchen devices that help prepare and cook delicious food and drink.
33. The travel industry's news landscape is rich with stories on sustainable living, healthy cooking, and adventure travel, informing consumers, businesses, and travelers alike on the newest trends and developments.
34. Businesses in the outdoor-living sector partner with technology companies to create durable, connected devices that enhance camping, hiking, and backyard activities for all.
35. The fusion of technology and business is reshaping the food-and-drink industry, with manufacturers and retailers working together to adapt to consumer preferences and environmental concerns.
36. The real-estate industry keeps an eye on the changing housing market, incorporating new technologies and optimizing layouts to meet the demands of modern living while fostering a healthy lifestyle.

Read also: